Prm21 - Modelling Survival of Patients With Completely Resected Advanced Melanoma With Adjuvant Treatment of Nivolumab Versus Observation

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

JAMA Oncology
Cancer ResearchOncology
2019English

Nivolumab Improves Survival for Patients With Advanced Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Dramatic Survival Benefit With Nivolumab in Melanoma

Cancer Discovery
Oncology
2016English

Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy for Patients With Completely Resected Advanced Lung Cancer: A Multicenter Randomized Controlled Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Ipilimumab Combined With Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?

Clinical Cancer Research
Cancer ResearchOncology
2016English

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma

JAMA Otolaryngology - Head and Neck Surgery
MedicineOtorhinolaryngologySurgery
2016English

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

JAMA Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy